| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the "Antonio Taticchi" Unit for Atherosclerosis and Thrombosis, Department of Vascular Medicine and Pharmacology, Istituto Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud (E.N., A.D.S., G.d.G., M.B.D., R.L.), S. Maria Imbaro; the Department of Immunology and Cell Biology, Istituto di Ricerche Farmacologiche Mario Negri (A.B., G.P., A.M.), Milano; and Istituto di Patologia Generale (A.M), University of Milano, Milano, Italy. Dr de Gaetano is now at Centro di Ricerche e Alta Formazione, Università Cattolica, Campobasso, Italy.
Correspondence to Dr Roberto Lorenzet, Consorzio Mario Negri Sud, Via Nazionale, 66030 S. Maria Imbaro, Italy. E-mail lorenzet{at}cmns.mnegri.it
Inflammation is a major contributing factor to atherosclerotic plaque development and ischemic heart disease. PTX3 is a long pentraxin that was recently found to be increased in patients with acute myocardial infarction. Because tissue factor (TF), the in vivo trigger of blood coagulation, plays a dominant role in thrombus formation after plaque rupture, we tested the possibility that PTX3 could modulate TF expression. Human umbilical vein endothelial cells, incubated with endotoxin (lipopolysaccharide) or the inflammatory cytokines interleukin-1ß and tumor necrosis factor-
, expressed TF. The presence of PTX3 increased TF activity and antigen severalfold in a dose-dependent fashion. PTX3 exerted its effect at the transcription level, inasmuch as the increased levels of TF mRNA, mediated by the stimuli, were enhanced in its presence. The increase in mRNA determined by PTX3 originated from an enhanced nuclear binding activity of the transacting factor c-Rel/p65, which was mediated by the agonists and measured by electrophoretic mobility shift assay. The mechanism underlying the increased c-Rel/p65 activity resided in an enhanced degradation of the c-Rel/p65 inhibitory protein I
B
. In the area of vascular injury, during the inflammatory response, cell-mediated fibrin deposition takes place. Our results suggest that PTX3, by increasing TF expression, potentially plays a role in thrombogenesis and ischemic vascular disease.
Key Words: tissue factor PTX3 inflammation coagulation endothelial cells
This article has been cited by other articles:
![]() |
Z. Mallat and A. Tedgui HDL, PTX3, and Vascular Protection Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 809 - 811. [Full Text] [PDF] |
||||
![]() |
M. Tong, J. J. Carrero, A. R. Qureshi, B. Anderstam, O. Heimburger, P. Barany, J. Axelsson, A. Alvestrand, P. Stenvinkel, B. Lindholm, et al. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He, B. Han, and M. Liu Long pentraxin 3 in pulmonary infection and acute lung injury Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1039 - L1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Okutani, B. Han, M. Mura, T. K. Waddell, S. Keshavjee, and M. Liu High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L144 - L153. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bottazzi, A. Bastone, A. Doni, C. Garlanda, S. Valentino, L. Deban, V. Maina, A. Cotena, F. Moalli, L. Vago, et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility J. Leukoc. Biol., May 1, 2006; 79(5): 909 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Montaner, I. Fernandez-Cadenas, C. A. Molina, M. Ribo, R. Huertas, A. Rosell, A. Penalba, L. Ortega, P. Chacon, and J. Alvarez-Sabin Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis Stroke, May 1, 2006; 37(5): 1205 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Han, M. Mura, C. F. Andrade, D. Okutani, M. Lodyga, C. C. dos Santos, S. Keshavjee, M. Matthay, and M. Liu TNF{alpha}-Induced Long Pentraxin PTX3 Expression in Human Lung Epithelial Cells via JNK J. Immunol., December 15, 2005; 175(12): 8303 - 8311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pandolfi C-reactive protein: A potential new molecular link between inflammation, thrombosis and vascular cell proliferation? Cardiovasc Res, October 1, 2005; 68(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
M. Camozzi, S. Zacchigna, M. Rusnati, D. Coltrini, G. Ramirez-Correa, B. Bottazzi, A. Mantovani, M. Giacca, and M. Presta Pentraxin 3 Inhibits Fibroblast Growth Factor 2-Dependent Activation of Smooth Muscle Cells In Vitro and Neointima Formation In Vivo Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1837 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Latini, A. P. Maggioni, G. Peri, L. Gonzini, D. Lucci, P. Mocarelli, L. Vago, F. Pasqualini, S. Signorini, D. Soldateschi, et al. Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction Circulation, October 19, 2004; 110(16): 2349 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Napoleone, A. Di Santo, G. Peri, A. Mantovani, G. de Gaetano, M. B. Donati, and R. Lorenzet The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation J. Leukoc. Biol., July 1, 2004; 76(1): 203 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rusnati, M. Camozzi, E. Moroni, B. Bottazzi, G. Peri, S. Indraccolo, A. Amadori, A. Mantovani, and M. Presta Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis Blood, July 1, 2004; 104(1): 92 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paffen, H. L. Vos, and R. M. Bertina C-Reactive Protein Does Not Directly Induce Tissue Factor in Human Monocytes Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 975 - 981. [Abstract] [Full Text] |
||||
![]() |
H. D. Danenberg, A. J. Szalai, R. V. Swaminathan, L. Peng, Z. Chen, P. Seifert, W. P. Fay, D. I. Simon, and E. R. Edelman Increased Thrombosis After Arterial Injury in Human C-Reactive Protein-Transgenic Mice Circulation, August 5, 2003; 108(5): 512 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bussolati, G. Peri, G. Salvidio, D. Verzola, A. Mantovani, and G. Camussi The Long Pentraxin Ptx3 Is Synthesized in IgA Glomerulonephritis and Activates Mesangial Cells J. Immunol., February 1, 2003; 170(3): 1466 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF] |
||||
![]() |
G. K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis Circ. Res., August 23, 2002; 91(4): 281 - 291. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |